Kowalski Mark 4
4 · Sierra Oncology, Inc. · Filed Aug 12, 2020
Insider Transaction Report
Form 4
Kowalski Mark
Chief Medical Officer
Transactions
- Award
Stock Option (right to buy)
2020-08-12+24,970→ 24,970 totalExercise: $12.15Exp: 2030-08-12→ Common Stock (24,970 underlying)
Footnotes (1)
- [F1]The option vests as to 25% of the total shares on August 10, 2021, and then 2.0833% of the total shares vest monthly thereafter, with 100% of the total shares vested on August 10, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date.